ConCallIQ
Go Pro
APOLLOHOSP Healthcare 09 Aug 2023

Apollohosp Ltd — Q1 FY24

Apollo Hospitals reported a solid Q1 FY24 with consolidated revenue of INR 4,418 crore (+16% YoY) and EBITDA of INR 509 crore (+4% YoY).

bullish medium
Compare with...
Revenue ₹4,418 Cr +16%
EBITDA ₹509 Cr +4%
PAT ₹173 Cr
EBITDA Margin 12%
Duration
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Occupancy ramp-up slower than expected

Overall occupancy at 62% remains below the 70% target, with new hospitals at 60% and some regions like Tamil Nadu seeing muted volumes due to seasonal factors.

medium · management_commentary
R

Margin pressure from new store additions and clinical investments

Combined pharmacy EBITDA margins are under pressure due to 20% of stores yet to reach breakeven, and new hospitals face margin drag from doctor hiring and marketing costs.

medium · management_commentary
R

Apollo 24|7 GMV growth may be impacted by discount reduction

The decision to reduce discounts and filter low-value orders led to a sequential decline in pharmacy GMV, and achieving the INR 3,000 crore GMV target may be challenging.

medium · analyst_question
R

Indraprastha Medical lease renewal uncertainty

Management deferred providing an update on the lease renewal for Indraprastha Medical, which could impact future operations and expansion plans.

low · analyst_question